SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
867.00    15.00 (1.76%)
Bid:
867.00
Ask:
873.00
Spread: 6.00 (0.692%)
Market Cap: £515.62m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Directorate Change

15 Jan 2024 07:00

RNS Number : 6132Z
Pollen Street PLC
15 January 2024
 

FOR IMMEDIATE RELEASE

15 January 2024

 

Pollen Street plc - Directorate Change

Pollen Street plc today announces that Lucy Tilley will join the Company as its next Chief Financial Officer. Lucy will also join the Board as an executive director. Lucy will succeed Julian Dale, who will be stepping down from the Board and as Chief Financial Officer following the publication of the 2023 financial results and a handover period. A further announcement will be made in due course once Lucy's start date has been confirmed.

Lucy is joining Pollen Street from Mortgage Advice Bureau (Holdings) Plc ("MAB"), where she has been Finance Director since 2015 and Chief Financial Officer since 2019. Prior to this, Lucy was a director in the corporate broking team at Canaccord Genuity Limited and is a chartered accountant.

Robert Sharpe, Chairman and Lindsey McMurray, Chief Executive Officer commented:

"On behalf of the Board we are delighted to be welcoming Lucy Tilley to the Company. Lucy brings a wealth of experience, which will help drive the Group through its next phase of growth. We would also like to take the opportunity to thank Julian for his dedication and contribution to the Group over the past 5 years."

 

Notes:

1. Remuneration arrangements

A statement containing the information required by Section 430(2B) of the Companies Act 2006 will be added to the company's website in due course. The Company also confirms that Lucy Tilley's remuneration will be in line with the Remuneration Policy adopted by the Company.

 

2. Regulatory disclosure

The Company confirms that in respect of Listing Rule 9.6.13(R), Lucy Tilley is an executive director of MAB. There are no details to disclose in respect of Listing Rule 9.6.13R (2)-(6).

 

 

About Pollen Street plc

Pollen Street plc is an alternative asset manager dedicated to investing with the financial and business services sectors across both Private Equity and Private Credit strategies. The business was founded in 2013 and has consistently delivered top tier returns alongside growing AuM.

Pollen Street benefits from a complementary set of asset management activities focused on managing third-party AuM (the "Asset Manager") together with on-balance sheet investments (the "Investment Company").

The Asset Manager raises capital from top tier investors and deploys it into its Private Equity and Private Credit strategies. The strong recurring revenues from this business enable us to deliver scalable growth.

The Investment Company invests in strategies aligned with core strategies of the group and today the investment portfolio is aligned with the private credit strategy. The portfolio is a well-diversified pool of primarily senior credit assets to high quality borrowers generating strong returns together with capital preservation. The portfolio consists of both direct investments and investments in funds managed by Pollen Street.

POLN is listed on the London Stock Exchange (ticker symbol: POLN). Further details are available at www.pollencap.com.

For further information about this announcement please contact:

Barclays Bank plc - Joint Broker

Neal West / Stuart Muress

+44 (0)20 7623 2323

 

Liberum Capital Limited - Joint Broker

Chris Clarke / Edward Mansfield

+44 (0)20 3100 2000

 

FGS Global

Chris Sibbald

Chris.Sibbald@fgsglobal.com

+44 (0)7855955531

 

Link Company Matters Limited - Corporate Secretary

polncosec@linkgroup.co.uk 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAVZLFFZFLEBBL
Date   Source Headline
1st Jun 20263:01 pmRNSTotal Voting Rights
27th May 20264:46 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:39 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSQ1 2026 Trading Update
6th May 20264:40 pmRNSDirector/PDMR Shareholding
1st May 20269:49 amRNSTotal Voting Rights
1st May 20268:12 amRNSResult of AGM
28th Apr 20264:31 pmRNSDirector/PDMR Shareholding
16th Apr 20265:31 pmRNSInvestor Presentation via Investor Meet Company
14th Apr 20267:00 amRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
27th Mar 202610:36 amRNSDirector/PDMR Shareholding
26th Mar 20264:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:30 amRNSDividend Declaration
26th Mar 20267:00 amRNSFull Year 2025 Trading Update
2nd Mar 202611:26 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20261:57 pmRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:32 pmRNSDirector/PDMR Shareholding
2nd Feb 20263:12 pmRNSTotal Voting Rights
30th Jan 202610:59 amRNSDirectorate changes
28th Jan 202611:37 amRNSDirector/PDMR Shareholding
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSDirectorate change
23rd Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20254:27 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20259:50 amRNSUpdate Statement on 2025 AGM Voting Results
1st Dec 202511:15 amRNSTotal Voting Rights
28th Nov 20256:23 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSQ3 2025 Trading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSAnnouncement of New Share Buyback Programme
16th Oct 20256:16 pmRNSHolding(s) in Company
3rd Oct 202511:32 amRNSDirector/PDMR Shareholding
1st Oct 20255:12 pmRNSDirector/PDMR Shareholding
30th Sep 20254:07 pmRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.